GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (STU:9II) » Definitions » Median PS Value

Biovica International AB (STU:9II) Median PS Value : €0.00 (As of Mar. 05, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Biovica International AB Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Biovica International AB's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 was €0.008. Biovica International AB's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is €0.00.

As of today (2025-03-05), Biovica International AB's share price is €0.1538. Biovica International AB's Median PS Value is €0.00. Therefore, Biovica International AB's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Biovica International AB's Median PS Value or its related term are showing as below:

STU:9II's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.71
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Biovica International AB Median PS Value Historical Data

The historical data trend for Biovica International AB's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Median PS Value Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biovica International AB Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biovica International AB's Median PS Value

For the Biotechnology subindustry, Biovica International AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Price-to-Median-PS-Value falls into.



Biovica International AB Median PS Value Calculation

Biovica International AB's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.008*0
=0.00

10-Year Median PS Ratio is 0.
Biovica International AB's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.008.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (STU:9II) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Biovica International AB's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.1538/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB Median PS Value Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines